TALKSPACE INC (TALK) Fundamental Analysis & Valuation

NASDAQ:TALK • US87427V1035

5.12 USD
+0.36 (+7.56%)
At close: Mar 9, 2026
5.11 USD
-0.01 (-0.2%)
After Hours: 3/9/2026, 7:28:54 PM

This TALK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to TALK. TALK was compared to 101 industry peers in the Health Care Providers & Services industry. TALK is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TALK shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. TALK Profitability Analysis

1.1 Basic Checks

  • In the past year TALK was profitable.
  • TALK had a positive operating cash flow in the past year.
  • In multiple years TALK reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: TALK reported negative operating cash flow in multiple years.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M

1.2 Ratios

  • TALK's Return On Assets of 5.78% is amongst the best of the industry. TALK outperforms 80.20% of its industry peers.
  • TALK has a better Return On Equity (6.66%) than 61.39% of its industry peers.
  • With a Return On Invested Capital value of 2.12%, TALK perfoms like the industry average, outperforming 43.56% of the companies in the same industry.
Industry RankSector Rank
ROA 5.78%
ROE 6.66%
ROIC 2.12%
ROA(3y)-2.29%
ROA(5y)-17.18%
ROE(3y)-2.84%
ROE(5y)-20.73%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • TALK's Profit Margin of 3.40% is fine compared to the rest of the industry. TALK outperforms 72.28% of its industry peers.
  • TALK has a Operating Margin (1.38%) which is in line with its industry peers.
  • TALK has a better Gross Margin (42.92%) than 71.29% of its industry peers.
  • In the last couple of years the Gross Margin of TALK has declined.
Industry RankSector Rank
OM 1.38%
PM (TTM) 3.4%
GM 42.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.19%
GM growth 5Y-8.04%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

9

2. TALK Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TALK is destroying value.
  • TALK has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TALK has more shares outstanding
  • TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 26.40 indicates that TALK is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of TALK (26.40) is better than 99.01% of its industry peers.
  • TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 26.4
ROIC/WACC0.24
WACC8.79%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 6.38 indicates that TALK has no problem at all paying its short term obligations.
  • TALK has a better Current ratio (6.38) than 96.04% of its industry peers.
  • TALK has a Quick Ratio of 6.38. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
  • TALK has a Quick ratio of 6.38. This is amongst the best in the industry. TALK outperforms 96.04% of its industry peers.
Industry RankSector Rank
Current Ratio 6.38
Quick Ratio 6.38
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

8

3. TALK Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 400.00% over the past year.
  • Looking at the last year, TALK shows a very strong growth in Revenue. The Revenue has grown by 22.00%.
  • TALK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.60% yearly.
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)22%
Revenue growth 3Y24.15%
Revenue growth 5Y24.6%
Sales Q2Q%29.31%

3.2 Future

  • Based on estimates for the next years, TALK will show a very strong growth in Earnings Per Share. The EPS will grow by 63.91% on average per year.
  • The Revenue is expected to grow by 21.19% on average over the next years. This is a very strong growth
EPS Next Y176.85%
EPS Next 2Y107.8%
EPS Next 3Y86.89%
EPS Next 5Y63.91%
Revenue Next Year24.14%
Revenue Next 2Y22.68%
Revenue Next 3Y20.93%
Revenue Next 5Y21.19%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6

2

4. TALK Valuation Analysis

4.1 Price/Earnings Ratio

  • TALK is valuated quite expensively with a Price/Earnings ratio of 102.40.
  • The rest of the industry has a similar Price/Earnings ratio as TALK.
  • When comparing the Price/Earnings ratio of TALK to the average of the S&P500 Index (26.46), we can say TALK is valued expensively.
  • Based on the Price/Forward Earnings ratio of 36.99, the valuation of TALK can be described as expensive.
  • TALK's Price/Forward Earnings is on the same level as the industry average.
  • TALK's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.65.
Industry RankSector Rank
PE 102.4
Fwd PE 36.99
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TALK is valued a bit more expensive than the industry average as 65.35% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 106.31
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TALK's earnings are expected to grow with 86.89% in the coming years.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y107.8%
EPS Next 3Y86.89%

0

5. TALK Dividend Analysis

5.1 Amount

  • No dividends for TALK!.
Industry RankSector Rank
Dividend Yield 0%

TALK Fundamentals: All Metrics, Ratios and Statistics

TALKSPACE INC

NASDAQ:TALK (3/9/2026, 7:28:54 PM)

After market: 5.11 -0.01 (-0.2%)

5.12

+0.36 (+7.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)05-04
Inst Owners65.36%
Inst Owner Change5.76%
Ins Owners4.18%
Ins Owner Change2.87%
Market Cap848.18M
Revenue(TTM)228.87M
Net Income(TTM)7.79M
Analysts81.43
Price Target6.63 (29.49%)
Short Float %3.95%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.74%
Min EPS beat(2)6.97%
Max EPS beat(2)26.5%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.53%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)1.3%
Revenue beat(4)1
Avg Revenue beat(4)-0.28%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)1.3%
Revenue beat(8)2
Avg Revenue beat(8)-0.97%
Revenue beat(12)6
Avg Revenue beat(12)1.22%
Revenue beat(16)8
Avg Revenue beat(16)0.53%
PT rev (1m)30%
PT rev (3m)27.87%
EPS NQ rev (1m)1.22%
EPS NQ rev (3m)15.7%
EPS NY rev (1m)7.17%
EPS NY rev (3m)19.75%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)-0.72%
Revenue NY rev (1m)1.55%
Revenue NY rev (3m)1.57%
Valuation
Industry RankSector Rank
PE 102.4
Fwd PE 36.99
P/S 3.71
P/FCF N/A
P/OCF 99.39
P/B 7.25
P/tB 7.46
EV/EBITDA 106.31
EPS(TTM)0.05
EY0.98%
EPS(NY)0.14
Fwd EY2.7%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.05
OCFY1.01%
SpS1.38
BVpS0.71
TBVpS0.69
PEG (NY)0.58
PEG (5Y)N/A
Graham Number0.89
Profitability
Industry RankSector Rank
ROA 5.78%
ROE 6.66%
ROCE 2.68%
ROIC 2.12%
ROICexc 10.01%
ROICexgc 11.55%
OM 1.38%
PM (TTM) 3.4%
GM 42.92%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-17.18%
ROE(3y)-2.84%
ROE(5y)-20.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.19%
GM growth 5Y-8.04%
F-Score7
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 370.12%
Cap/Sales 4.65%
Interest Coverage 250
Cash Conversion 141.6%
Profit Quality N/A
Current Ratio 6.38
Quick Ratio 6.38
Altman-Z 26.4
F-Score7
WACC8.79%
ROIC/WACC0.24
Cap/Depr(3y)338.8%
Cap/Depr(5y)215.13%
Cap/Sales(3y)2.55%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y176.85%
EPS Next 2Y107.8%
EPS Next 3Y86.89%
EPS Next 5Y63.91%
Revenue 1Y (TTM)22%
Revenue growth 3Y24.15%
Revenue growth 5Y24.6%
Sales Q2Q%29.31%
Revenue Next Year24.14%
Revenue Next 2Y22.68%
Revenue Next 3Y20.93%
Revenue Next 5Y21.19%
EBIT growth 1Y170.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1410.19%
EBIT Next 3Y217.92%
EBIT Next 5Y130.97%
FCF growth 1Y-133.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.08%
OCF growth 3YN/A
OCF growth 5YN/A

TALKSPACE INC / TALK FAQ

What is the fundamental rating for TALK stock?

ChartMill assigns a fundamental rating of 6 / 10 to TALK.


Can you provide the valuation status for TALKSPACE INC?

ChartMill assigns a valuation rating of 2 / 10 to TALKSPACE INC (TALK). This can be considered as Overvalued.


What is the profitability of TALK stock?

TALKSPACE INC (TALK) has a profitability rating of 4 / 10.


What is the valuation of TALKSPACE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TALKSPACE INC (TALK) is 102.4 and the Price/Book (PB) ratio is 7.25.